Rushi Parikh is an Assistant Clinical Professor in the Division of Cardiology at UCLA Health. He is an interventional and advanced heart failure cardiologist actively involved in clinical research, with over 20 peer-reviewed publications. Currently funded by an American Heart Association Career Development Award, Rushi is investigating the role of endothelin-1 of cardiac allograft vasculopathy in heart transplant recipients. He also serves as a co-investigator on a number of clinical trials at UCLA, including COLHEART-19, which is evaluating the impact of the anti-inflammatory drug colchicine on outcomes in patients with COVID-19 and evidence of cardiac injury. Additionally, Rushi is a scientific advisor to several early-stage medical device and digital health start-up companies, including Stallion Cardio, HeartCloud, and DocVocate. Rushi completed his fellowships in general and interventional cardiology at Stanford University, following his internal medicine residency and advanced heart failure training at the UC San Francisco. Rushi earned his MD from New York University and his BA in Biology and Economics from Cornell University.